Consequently, we recognized that STAT1 and NF-κB pathways can be a key target of PE-EPS for IBD, and at the same time considered that further work will be required to delineate the regulation of crosstalk between STAT1 and NF-κB in various molecular biological analysis. The gene discussed is STAT1; the disease is inflammatory bowel disease.